DrugPatentWatch Database Preview
Litigation Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
» See Plans and Pricing
Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
Docket | Start Trial | Date Filed | 2011-04-01 |
Court | District Court, N.D. California | Date Terminated | 2013-11-01 |
Cause | 35:271 Patent Infringement | Assigned To | Joseph C. Spero |
Jury Demand | None | Referred To | Jacqueline Scott Corley |
Parties | HANDA PHARMACEUTICALS, LLC; IMPAX LABORATORIES, INC.; IMPAX LABORATORIES, INC.,; PAR PHARMACEUTICAL, INC.; SANDOZ INC.; TAKEDA PHARMACEUTICAL CO., LTD.; TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. | ||
Patents | 6,162,463; 6,228,398; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755 | ||
Attorneys | Brian Francis McMahon; David C. Doyle; Edward George Dane; Eric Martin Acker; Erin Joan Cox; Heather E. Takahashi; Jeffrey I. Weinberger; Jessica E. La Londe; Joel Matthew Purles; Marc Dana Sharp; Mark T. Jansen; Parisa Jorjani; Pilar Stillwater; Ryan Neil Hagglund; Ted G. Dane , Esq.; Tina Wang Arroyo | ||
Firms | Christensen O'Connor Johnson Kindness PLLC; Crowell and Moring LLP; Morrison & Foerster LLP; Morrison and Foerster; Munger Tolles & Olson LLP; Munger Tolles Olson LLP; Munger, Tolles & Olson LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc.
Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2011-04-01 | 1 | 6,162,463 A 1212000 Lippa (73) Assignee: …U.S. Patent No. 6,462,058 (the “’058 12 Patent”), U.S. Patent No. 6,664,276 (the “’276 Patent”), U.…U.S. Patent No. 6,939,971 (the “’971 13 Patent”), U.S. Patent No. 7,285,668 (the “’668 Patent”), and…and U.S. Patent No. 7,790,755 (the “’755 14 Patent”) (collectively, the “Asserted Patents”). 15 …3 A. Asserted Patents 4 1. The ’058 Patent 5 13. On October | External link to document | |
2013-05-28 | 305 | of U.S. Patent No. 6,462,058 (the '''058 patent"); U.S. Patent No. 6,664,276… TX0001 U.S. Patent No.6,462,058 …Extrinsic Evidence for U.S. Patent No. 6,462,058 TX0064x03 The United States Pharmacopeia…TX0064x07 Prosecution History for U.S. Patent No. 6,462,058, Original Claims DEX0001343 …TX0064x08 Prosecution History for U.S. Patent No. 6,462,058, Office Action DEX0001579 | External link to document | |
2013-05-30 | 308 | infringe U.S. Patent No. 6,462,058 ("the '058 23 Patent"), U.S. Patent No. 6,… 24 Patent") and U.S. Patent No. 7,790,755 ("the '75 5 Patent") (collectively…6,664,276 ("the '276 Patent"), U.S. Patent No. 6,939,971 ("the '971 …infringed U.S. Patent No. 27 7,285,668 ("the '668 Patent").…based on the '668 Patent, as well as Impax's counterclaims based on that patent, pursuant | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |